Clinical Pharmacokinetics - PowerPoint PPT Presentation

About This Presentation
Title:

Clinical Pharmacokinetics

Description:

Pharmacokinetics vs Pharmacodynamics concept If fluoxetine is given with tramadol serotonin syndrom can result. This is a pharmacodynamic drug interaction. – PowerPoint PPT presentation

Number of Views:270
Avg rating:3.0/5.0
Slides: 40
Provided by: philadelp2
Category:

less

Transcript and Presenter's Notes

Title: Clinical Pharmacokinetics


1
Clinical Pharmacokinetics
  • Introduction

2
How to use this powerpoint presentation
  • This supplements the other course material
  • You can view it on line or download it to your
    computer and view it without being connected to
    the internet.
  • Work through the presentation at the start of the
    course and note any issue which are not clear.
  • Read up on areas that you are not familiar with
    and revisit the presentation from time to time.
  • Try the powerpoint based exercises

3
What is clinical pharmacokinetics ?
  • Study of the time course of a drugs movement
    through the body.
  • Understanding of what the body does to (or with)
    the drug.
  • Application of Therapeutic Drug Monitoring (TDM)
    and individualisation of drug therapy.

4
Outline
  • Review of Concepts
  • Clearance, K, Half-Life, Volume of Distribution
  • Therapeutic drug Monitoring
  • Pharmacokinetic Drug Interactions
  • Cases
  • Discussion/Questions

5
Pharmacokinetics (PK) pharmacodynamics (PD)
  • PK - What the body does to the drug?
  • Absorption distribution, metabolism, excretion
    (ADME)
  • PD - What the drug does to the body?
  • Drug concentration at the site of action or in
    the plasma is related to a magnitude of effect

6
Pharmacokinetics (PK) and pharmacodynamics (PD)
Plasma Site
Concen- of
tration Action
Dose
Effects
PK
PD
7
Pharmacokinetics vs Pharmacodynamicsconcept
  • Fluoxetine increases plasma concentrations of
    amitriptyline. This is a pharmacokinetic drug
    interaction.
  • Fluoxetine inhibits the metabolism of
    amitriptyline and increases the plasma
    concentration of amitriptytline.

8
Pharmacokinetics vs Pharmacodynamicsconcept
  • If fluoxetine is given with tramadol serotonin
    syndrom can result. This is a pharmacodynamic
    drug interaction.
  • Fluoxetine and tramadol both increase
    availability of serotonin leading to the
    possibility of serotonin overload This happens
    without a change in the concentration of either
    drug.

9
Basic Parameters
  • In the next few slides the basic concepts and
    paramaters will be described and explained.
  • In pharmacokinetics the body is represented as a
    single or multiple compartments in to which the
    drug is distributed.
  • Some of the parameters are therefore a little
    abstract as we know the body is much more
    complicated !

10
Volume of Distribution, Clearance and Elimination
Rate Constant
V
Volume 100 L
Clearance 10 L/hr
11
Volume of Distribution, Clearance and Elimination
Rate Constant
V
Volume 100 L (Vi)
V2 Cardiac and Skeletal Muscle
Clearance 10 L/hr
12
Volume 100 L (Vi)
V2 Cardiac and Skeletal Muscle
V
Clearance 10 L/hr
Volume of Distribution
Dose_______ Plasma Concentration
13
Volume 100 L (Vi)
V2 Cardiac and Skeletal Muscle
V
Clearance 10 L/hr
Clearance Volume of blood cleared of drug per
unit time
14
Volume 100 L (Vi)
V2 Cardiac and Skeletal Muscle
V
Clearance 10 L/hr
Clearance 10 L/hr Volume of Distribution 100
L What is the Elimination Rate Constant (k) ?
15
CL kV k 10 Lhr -1 0.1 hr -1
100 L
10 of the Volume is cleared (of drug) per
hour k Fraction of drug in the body removed
per hour
16
CL kV
If V increases then k must decrease as CL is
constant
17
Important Concepts
  • VD is a theoretical Volume and determines the
    loading dose
  • Clearance is a constant and determines the
    maintenance dose
  • CL kVD
  • CL and VD are independent variables
  • k is a dependent variable

18
Volume of Distribution
  • Apparent volume of distribution is the
    theoretical volume that would have to be
    available for drug to disperse in if the
    concentration everywhere in the body were the
    same as that in the plasma or serum, the place
    where drug concentration sampling generally
    occurs.

19
Volume of Distribution
  • An abstract concept
  • Gives information on HOW the drug is distributed
    in the body
  • Used to calculate a loading dose

20
Loading Dose
Dose Cp(Target) x VD
21
Question
  • What Is the is the loading dose required fro drug
    A if
  • Target concentration is 10 mg/L
  • VD is 0.75 L/kg
  • Patients weight is 75 kg
  • Answer is on the next slide

22
Answer Loading Dose of Drug A
  • Dose Target Concentration x VD
  • VD 0.75 L/kg x 75 kg 56.25 L
  • Target Conc. 10 mg/L
  • Dose 10 mg/L x 56.25 L
  • 565 mg
  • This would probably be rounded to 560 or even 500
    mg.

23
Clearance
  • Ability of organs of elimination (e.g. kidney,
    liver to clear drug from the bloodstream
  • Volume of fluid which is completely cleared of
    drug per unit time
  • Units are in L/hr or L/hr/kg
  • Pharmacokinetic term used in determination of
    maintenance doses

24
Maintenance DoseCalculation
  • Maintenance Dose CL x CpSSav
  • CpSSav is the target average steady state drug
    concentration
  • The units of CL are in L/hr or L/hr/kg
  • Maintenance dose will be in mg/hr so for total
    daily dose will need multiplying by 24

25
Question
  • What maintenance dose is required for drug A if
  • Target average SS concentration is 10 mg/L
  • CL of drug A is 0.015 L/kg/hr
  • Patient weighs 75 kg
  • Answer on next slide.

26
Answer
  • Maintenance Dose CL x CpSSav
  • CL 0.015 L/hr/kg x 75 1.125 L/hr
  • Dose 1.125 L/hr x 10 mg/L 11.25 mg/hr
  • So will need 11.25 x 24 mg per day 270 mg

27
Half-Life and k
  • Half-life is the time taken for the drug
    concentration to fall to half its original value
  • The elimination rate constant (k) is the fraction
    of drug in the body which is removed per unit
    time.

28
Exponential decay
dC/dt ? C
-k.C
C2
29
C0
C0/2
t1/2
t1/2
t1/2
30
Integrating
Logarithmic transform
lnC2 lnC1 - kt
logC2 logC1 - kt/2.303
Elimination Half-Life
t1/2 ln2/k
31
Steady-State
  • Steady-state occurs after a drug has been given
    for approximately five elimination half-lives.
  • At steady-state the rate of drug administration
    equals the rate of elimination and plasma
    concentration - time curves found after each dose
    should be approximately superimposable.

32
Accumulation to Steady State 100 mg given every
half-life
200

194
187.5
175
150
100

97
100
94
87.5
75
50
33
(No Transcript)
34
What is Steady State (SS) ?Why is it important ?
  • Rate in Rate Out
  • Reached in 4 5 half-lives (linear kinetics)
  • Important when interpreting drug concentrations
    in TDM or assessing clinical response

35
Therapeutic Drug Monitoring
  • Some Principles

36
Therapeutic Index
  • Therapeutic index toxic dose/effective dose
  • This is a measure of a drugs safety
  • A large number a wide margin of safety
  • A small number a small margin of safety

37
Drug Concentrations May BeUseful When There Is
  • An established relationship between
    concentration and response or toxicity
  • A sensitive and specific assay
  • An assay that is relatively easy to perform
  • A narrow therapeutic range
  • A need to enhance response/preventtoxicity

38
Why Measure Drug Concentrations?
  • Lack of therapeutic response
  • Toxic effects evident
  • Potential for non-compliance
  • Variability in relationship of dose
    andconcentration
  • Therapeutic/toxic actions not easilyquantified
    by clinical endpoints

39
Potential for Error When Using TDM
  • Assuming patient is at steady-state
  • Assuming patient is actually taking the drug as
    prescribed
  • Assuming patient is receiving drug as prescribed
  • Not knowing when the drug concentration was
    measured inrelation to dose administration
  • Assuming the patient is static and that changes
    in condition dont affect clearance
  • Not considering drug interactions
Write a Comment
User Comments (0)
About PowerShow.com